The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of intravesical nadofaragene firadenovec for patients with high-grade, BCG unresponsive nonmuscle invasive bladder cancer (NMIBC): Results from a phase III trial.
Stephen A. Boorjian
Consulting or Advisory Role - Ferring; Sanofi
Colin P.N. Dinney
Consulting or Advisory Role - FKD Therapies; Merck; NCI
Research Funding - FKD Therapies; Merck; NCI; University of Eastern Finland (Inst)